Context Therapeutics Inc. Development Agreements
5 Contracts & Agreements
- Development and Manufacturing Services Agreement, dated November (Filed With SEC on November 9, 2022)
- Amendment No. 3 to Process Development Agreement (Filed With SEC on November 9, 2022)
- Amendment No. 2 to Process Development Agreement, dated June 3, 2021, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited (Filed With SEC on June 16, 2021)
- Amendment No. 1 to Process Development Agreement, dated April 21, 2021, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited (Filed With SEC on May 27, 2021)
- Process Development Agreement, dated March 6, 2020, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited (Filed With SEC on May 27, 2021)
